Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 5/2014

01.09.2014 | Original Article

Effects of hematopoietic stem cell transplantation on acyl-CoA oxidase deficiency: a sibling comparison study

verfasst von: Raymond Y. Wang, Edwin S. Monuki, James Powers, Phillip H. Schwartz, Paul A. Watkins, Yang Shi, Ann Moser, David A. Shrier, Hans R. Waterham, Diane J. Nugent, Jose E. Abdenur

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Objective

Acyl-CoA oxidase (ACOX1) deficiency is a rare disorder of peroxisomal very-long chain fatty acid oxidation. No reports detailing attempted treatment, longitudinal imaging, or neuropathology exist. We describe the natural history of clinical symptoms and brain imaging in two siblings with ACOX1 deficiency, including the younger sibling’s response to allogeneic unrelated donor hematopoietic stem cell transplantation (HSCT).

Methods

We conducted retrospective chart review to obtain clinical history, neuro-imaging, and neuropathology data. ACOX1 genotyping were performed to confirm the disease. In vitro fibroblast and neural stem cell fatty acid oxidation assays were also performed.

Results

Both patients experienced a fatal neurodegenerative course, with late-stage cerebellar and cerebral gray matter atrophy. Serial brain magnetic resonance imaging in the younger sibling indicated demyelination began in the medulla and progressed rostrally to include the white matter of the cerebellum, pons, midbrain, and eventually subcortical white matter. The successfully engrafted younger sibling had less brain inflammation, cortical atrophy, and neuronal loss on neuro-imaging and neuropathology compared to the untreated older sister. Fibroblasts and stem cells demonstrated deficient very long chain fatty acid oxidation.

Interpretation

Although HSCT did not halt the course of ACOX1 deficiency, it reduced the extent of white matter inflammation in the brain. Demyelination continued because of ongoing neuronal loss, which may be due to inability of transplant to prevent progression of gray matter disease, adverse effects of chronic corticosteroid use to control graft-versus-host disease, or intervention occurring beyond a critical point for therapeutic efficacy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Aubourg P, Blanche S, Jambaqué I et al (1990) Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med 322:1860–1866PubMedCrossRef Aubourg P, Blanche S, Jambaqué I et al (1990) Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med 322:1860–1866PubMedCrossRef
Zurück zum Zitat Berciano J (1982) Olivopontocerebellar atrophy. A review of 117 cases. J Neurol Sci 53:253–272PubMedCrossRef Berciano J (1982) Olivopontocerebellar atrophy. A review of 117 cases. J Neurol Sci 53:253–272PubMedCrossRef
Zurück zum Zitat Carrozzo R, Bellini C, Lucioli S et al (2008) Peroxisomal acyl-CoA-oxidase deficiency: two new cases. Am J Med Genet A 146A:1676–1681PubMedCrossRef Carrozzo R, Bellini C, Lucioli S et al (2008) Peroxisomal acyl-CoA-oxidase deficiency: two new cases. Am J Med Genet A 146A:1676–1681PubMedCrossRef
Zurück zum Zitat El Hajj HI, Vluggens A, Andreoletti P et al (2012) The inflammatory response in acyl-CoA oxidase 1 deficiency (pseudoneonatal adrenoleukodystrophy). Endocrinology 153:2568–2575PubMedCentralPubMedCrossRef El Hajj HI, Vluggens A, Andreoletti P et al (2012) The inflammatory response in acyl-CoA oxidase 1 deficiency (pseudoneonatal adrenoleukodystrophy). Endocrinology 153:2568–2575PubMedCentralPubMedCrossRef
Zurück zum Zitat Farioli-Vecchioli S, Moreno S, Cerù MP (2001) Immunocytochemical localization of acyl-CoA oxidase in the rat central nervous system. J Neurocytol 30:21–33PubMedCrossRef Farioli-Vecchioli S, Moreno S, Cerù MP (2001) Immunocytochemical localization of acyl-CoA oxidase in the rat central nervous system. J Neurocytol 30:21–33PubMedCrossRef
Zurück zum Zitat Ferdinandusse S, Denis S, Hogenhout EM et al (2007) Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency. Hum Mutat 28:904–912PubMedCrossRef Ferdinandusse S, Denis S, Hogenhout EM et al (2007) Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency. Hum Mutat 28:904–912PubMedCrossRef
Zurück zum Zitat Ferdinandusse S, Barker S, Lachlan K et al (2010) Adult peroxisomal acyl-coenzyme A oxidase deficiency with cerebellar and brainstem atrophy. J Neurol Neurosurg Psychiatry 81:310–312PubMedCrossRef Ferdinandusse S, Barker S, Lachlan K et al (2010) Adult peroxisomal acyl-coenzyme A oxidase deficiency with cerebellar and brainstem atrophy. J Neurol Neurosurg Psychiatry 81:310–312PubMedCrossRef
Zurück zum Zitat Fouquet F, Zhou JM, Ralston E et al (1997) Expression of the adrenoleukodystrophy protein in the human and mouse central nervous system. Neurobiol Dis 3:271–285PubMedCrossRef Fouquet F, Zhou JM, Ralston E et al (1997) Expression of the adrenoleukodystrophy protein in the human and mouse central nervous system. Neurobiol Dis 3:271–285PubMedCrossRef
Zurück zum Zitat Ghatak NR, Nochlin D, Peris M, Myer EC (1981) Morphology and distribution of cytoplasmic inclusions in adrenoleukodystrophy. J Neurol Sci 50:391–398PubMedCrossRef Ghatak NR, Nochlin D, Peris M, Myer EC (1981) Morphology and distribution of cytoplasmic inclusions in adrenoleukodystrophy. J Neurol Sci 50:391–398PubMedCrossRef
Zurück zum Zitat Hein S, Schönfeld P, Kahlert S, Reiser G (2008) Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture. Hum Mol Genet 17:1750–1761PubMedCrossRef Hein S, Schönfeld P, Kahlert S, Reiser G (2008) Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture. Hum Mol Genet 17:1750–1761PubMedCrossRef
Zurück zum Zitat Iwata NK, Kwan JY, Danielian LE et al (2011) White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain 134:2642–2655PubMedCentralPubMedCrossRef Iwata NK, Kwan JY, Danielian LE et al (2011) White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain 134:2642–2655PubMedCentralPubMedCrossRef
Zurück zum Zitat Jia Z, Moulson CL, Pei Z et al (2007) FATP4 is the principal very long-chain fatty acyl-CoA synthetase in skin fibroblasts. J Biol Chem 282:20573–20583PubMedCrossRef Jia Z, Moulson CL, Pei Z et al (2007) FATP4 is the principal very long-chain fatty acyl-CoA synthetase in skin fibroblasts. J Biol Chem 282:20573–20583PubMedCrossRef
Zurück zum Zitat Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 5:1073–1081CrossRef Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 5:1073–1081CrossRef
Zurück zum Zitat Kurian MA, Ryan S, Besley GT et al (2004) Straight-chain acyl-CoA oxidase deficiency presenting with dysmorphia, neurodevelopmental autistic-type regression and a selective pattern of leukodystrophy. J Inherit Metab Dis 27:105–108PubMedCrossRef Kurian MA, Ryan S, Besley GT et al (2004) Straight-chain acyl-CoA oxidase deficiency presenting with dysmorphia, neurodevelopmental autistic-type regression and a selective pattern of leukodystrophy. J Inherit Metab Dis 27:105–108PubMedCrossRef
Zurück zum Zitat Loes DJ, Hite S, Moser H et al (1994) Adrenoleukodystrophy: a scoring method for brain MR observations. Am J Neuroradiol 15:1761–1766PubMed Loes DJ, Hite S, Moser H et al (1994) Adrenoleukodystrophy: a scoring method for brain MR observations. Am J Neuroradiol 15:1761–1766PubMed
Zurück zum Zitat Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed
Zurück zum Zitat Miller WP, Rothman SM, Nascene D et al (2011) Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood 118:1971–1978PubMedCrossRef Miller WP, Rothman SM, Nascene D et al (2011) Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood 118:1971–1978PubMedCrossRef
Zurück zum Zitat Padovan CS, Yousry TA, Schleuning M et al (1998) Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation. Ann Neurol 43:627–633PubMedCrossRef Padovan CS, Yousry TA, Schleuning M et al (1998) Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation. Ann Neurol 43:627–633PubMedCrossRef
Zurück zum Zitat Peters C, Charnas LR, Tan Y et al (2004) Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 104:881–888PubMedCrossRef Peters C, Charnas LR, Tan Y et al (2004) Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 104:881–888PubMedCrossRef
Zurück zum Zitat Poll-The BT, Roels F, Ogier H et al (1988) A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy). Am J Hum Genet 42:422–434PubMedCentralPubMed Poll-The BT, Roels F, Ogier H et al (1988) A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy). Am J Hum Genet 42:422–434PubMedCentralPubMed
Zurück zum Zitat Powers JM, Moser HW (1998) Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis. Brain Pathol 8:101–120PubMedCrossRef Powers JM, Moser HW (1998) Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis. Brain Pathol 8:101–120PubMedCrossRef
Zurück zum Zitat Powers JM, Moser HW, Moser AB, Schaumburg HH (1982) Fetal adrenoleukodystrophy: the significance of pathologic lesions in adrenal gland and testis. Hum Pathol 13:1013–1019PubMedCrossRef Powers JM, Moser HW, Moser AB, Schaumburg HH (1982) Fetal adrenoleukodystrophy: the significance of pathologic lesions in adrenal gland and testis. Hum Pathol 13:1013–1019PubMedCrossRef
Zurück zum Zitat Rosewich H, Waterham HR, Wanders RJ et al (2006) Pitfall in metabolic screening in a patient with fatal peroxisomal beta-oxidation defect. Neuropediatrics 37:95–98PubMedCrossRef Rosewich H, Waterham HR, Wanders RJ et al (2006) Pitfall in metabolic screening in a patient with fatal peroxisomal beta-oxidation defect. Neuropediatrics 37:95–98PubMedCrossRef
Zurück zum Zitat Schaumberg HH, Powers JM, Raine CS et al (1975) Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol 32:577–591CrossRef Schaumberg HH, Powers JM, Raine CS et al (1975) Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol 32:577–591CrossRef
Zurück zum Zitat Schwartz PH, Bryant PJ, Fuja TJ et al (2003) Isolation and characterization of neural progenitor cells from post-mortem human cortex. J Neurosci Res 74:838–851PubMedCrossRef Schwartz PH, Bryant PJ, Fuja TJ et al (2003) Isolation and characterization of neural progenitor cells from post-mortem human cortex. J Neurosci Res 74:838–851PubMedCrossRef
Zurück zum Zitat Shapiro E, Krivit W, Lockman L et al (2000) Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 356:713–718PubMedCrossRef Shapiro E, Krivit W, Lockman L et al (2000) Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 356:713–718PubMedCrossRef
Zurück zum Zitat Suzuki Y, Shimozawa N, Yajima S et al (1994) Novel subtype of peroxisomal acyl-CoA oxidase deficiency and bifunctional enzyme deficiency with detectable enzyme protein: identification by means of complementation analysis. Am J Hum Genet 54:36–43PubMedCentralPubMedCrossRef Suzuki Y, Shimozawa N, Yajima S et al (1994) Novel subtype of peroxisomal acyl-CoA oxidase deficiency and bifunctional enzyme deficiency with detectable enzyme protein: identification by means of complementation analysis. Am J Hum Genet 54:36–43PubMedCentralPubMedCrossRef
Zurück zum Zitat Suzuki Y, Iai M, Kamei A et al (2002) Peroxisomal acyl CoA oxidase deficiency. J Pediatr 140:128–130PubMedCrossRef Suzuki Y, Iai M, Kamei A et al (2002) Peroxisomal acyl CoA oxidase deficiency. J Pediatr 140:128–130PubMedCrossRef
Zurück zum Zitat Terao S, Sobue G, Yasuda T et al (1995) Magnetic resonance imaging of the corticospinal tracts in amyotrophic lateral sclerosis. J Neurol Sci 133:66–72PubMedCrossRef Terao S, Sobue G, Yasuda T et al (1995) Magnetic resonance imaging of the corticospinal tracts in amyotrophic lateral sclerosis. J Neurol Sci 133:66–72PubMedCrossRef
Zurück zum Zitat van der Knaap MS, Wassmer E, Wolf NI et al (2012) MRI as diagnostic tool in early-onset peroxisomal disorders. Neurology 78:1304–1308PubMedCrossRef van der Knaap MS, Wassmer E, Wolf NI et al (2012) MRI as diagnostic tool in early-onset peroxisomal disorders. Neurology 78:1304–1308PubMedCrossRef
Zurück zum Zitat Wanders RJ, Schelen A, Feller N et al (1990) First prenatal diagnosis of acyl-CoA oxidase deficiency. J Inherit Metab Dis 13:371–374PubMedCrossRef Wanders RJ, Schelen A, Feller N et al (1990) First prenatal diagnosis of acyl-CoA oxidase deficiency. J Inherit Metab Dis 13:371–374PubMedCrossRef
Zurück zum Zitat Watkins PA, McGuinness MC, Raymond GV et al (1995) Distinction between peroxisomal bifunctional enzyme and acyl-CoA oxidase deficiencies. Ann Neurol 38:472–477PubMedCrossRef Watkins PA, McGuinness MC, Raymond GV et al (1995) Distinction between peroxisomal bifunctional enzyme and acyl-CoA oxidase deficiencies. Ann Neurol 38:472–477PubMedCrossRef
Zurück zum Zitat Zivadinov R (2005) Steroids and brain atrophy in multiple sclerosis. J Neurol Sci 233:73–81PubMedCrossRef Zivadinov R (2005) Steroids and brain atrophy in multiple sclerosis. J Neurol Sci 233:73–81PubMedCrossRef
Metadaten
Titel
Effects of hematopoietic stem cell transplantation on acyl-CoA oxidase deficiency: a sibling comparison study
verfasst von
Raymond Y. Wang
Edwin S. Monuki
James Powers
Phillip H. Schwartz
Paul A. Watkins
Yang Shi
Ann Moser
David A. Shrier
Hans R. Waterham
Diane J. Nugent
Jose E. Abdenur
Publikationsdatum
01.09.2014
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 5/2014
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-014-9698-3

Weitere Artikel der Ausgabe 5/2014

Journal of Inherited Metabolic Disease 5/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.